Marshall Fordyce - 01 Sep 2022 Form 4/A - Amendment Insider Report for Vera Therapeutics, Inc. (VERA)

Role
President and CEO, Director
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
13 Sep 2022, 16:09:00 UTC
Date Of Original Report
06 Sep 2022
Previous filing
23 Aug 2022
Next filing
09 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VERA Stock Option (right to buy) 1,069,584 01 Sep 2022 Class A Common Stock 17,100 $2.90 Direct F1, F2
holding VERA Stock Option (right to buy) 1,052,488 01 Sep 2022 Class A Common Stock 17,096 $2.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vested on December 16, 2021, and 1/48 of the shares vest monthly thereafter.
F2 The reporting person's original Form 4 contained a typographical error on the total number of derivative securities beneficially owned following the reported transaction.